Roche

News

NICE backs chemo-free CLL combination from AbbVie and Roche

Previously untreated patients with chronic lymphocytic leukaemia (CLL) in England will get a chemotherapy-free treatment option after NICE recommended NHS funding for a combination of AbbVi

News

Sanofi/Alnylam's haemophilia drug hits another safety speed-...

Sanofi’s attempt to take on Roche with a ground-breaking approach to treating haemophilia has hit a setback after the company voluntarily placed its late-stage trials of fitusiran on hold b

News

Europe approves Roche's Tecentriq liver cancer combination

The European Commission has approved Roche’s Tecentriq immunotherapy, in combination with its established cancer drug Avastin, for patients with the most common form of liver cancer.

News

Roche to co-develop remdesivir rival in partnership with Ate...

Roche may not be the first company that comes to mind for a COVID-19 treatment, but the Swiss firm is taking a big swing at the market to rival Gilead’s

News

FDA grants full approval for Roche/AbbVie's Venclexta in AML...

Combination therapies involving Roche and AbbVie’s cancer drug Venclexta have been formally approved by the FDA in acute myeloid leukaemia, following supportive data from late-stage studies

News

COVID-19 tests prop up Roche as US biosimilars bite in Q3

Roche’s pharmaceutical revenues have been hit by falling sales in its pharma division in Q3 but a spike in demand for COVID-19 tests spared the Swiss company's blushes.

NICE backs chemo-free CLL combination from AbbVie and Roche

Sanofi/Alnylam's haemophilia drug hits another safety speed-...

Europe approves Roche's Tecentriq liver cancer combination

Roche to co-develop remdesivir rival in partnership with Ate...

FDA grants full approval for Roche/AbbVie's Venclexta in AML...

COVID-19 tests prop up Roche as US biosimilars bite in Q3

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Roche

Editor's Picks